MediPrint™ Ophthalmics is an emerging pharmaceutical company based in San Diego developing and commercializing a proprietary ocular drug delivery portfolio.

MediPrint Ophthalmics

MediPrint™ Ophthalmics

MediPrint Ophthalmics | 539 followers on LinkedIn. Enhancing Vision for Life | Enhancing vision for life with a patented contact lens based drug delivery portfolio.

Corporate Development | Partnerships | Strategic Growth

Sanjeev Ganatra

Director of Quality at MediPrint Ophthalmics

P.N. Balasubramanian

Bruce Holm

Senior Research Fellow

Furqan Maulvi

Thank you The Medicine Maker for the terrific article about MediPrint Ophthalmics and our founder Praful Doshi . #drugdelivery #contactlenses #glaucoma #enhancingvisionforlife https://lnkd.in/g-n76mSx

Mediprint will be at the American Academy Of Optometry meeting in #Indianapolis November 7-9. We look forward to seeing the optometric community, our partners and clinical colleagues. Certainly reach out to us if you will be attending so we can schedule time to meet. For those attending please make sure to attend the following presentations: Wednesday, November 6th (1:00pm EST) Dr. Walter Whitley and Dr. Justin Schweitzer, OD, FAAO - "Advances in Ocular Drug Delivery" (Indianapolis Convention Center; Room Sagamore 3-5; GO-04) Friday, November 8th (11:30am EST) Dr. I. Ben Gaddie, O.D., F.A.A.O. - "Clinical Successes with Sustained Delivery of Bimatoprost and Hyaluronic Acid from Contact Lenses Using Digital Printing Technology to Manage Glaucoma" (Indianapolis Convention Center; Wabash Ballroom) Part of Drugs, Devices, and New Discoveries: Dive into Optometry’s Evolution and Expansion Praful Doshi David Fancher CBCC Global Research Sanjeev Ganatra #optometry , #drugdelivery , #ophthalmology , #glaucoma , #contactlens MediPrint Ophthalmics #Academy24

We are grateful for being a sponsor at Octane 2024 and are excited for our enhancement of comfort for contact lens wearer in our phase 3 clinical study for sustained delivery for Glaucoma. Check out the video below of our founder and CEO Praful Doshi talking about our product pipeline! #enhancingvisionforlife #glaucoma #contactlenses #helpprotectsight #drugdelivery #ophthalmology #dryeye

We are excited to announce we have successfully completed our Phase 2b Glaucoma Clinical study with positive results. SIGHT-2 study evaluated safety and efficacy of LL-BMT-1 in 28 patients diagnosed with open-angle Glaucoma for three weeks. Results show clinically meaningful and sustained IOP reduction over the duration of 3 weeks which is statistically comparable to 0.01% bimatoprost eye drops. Learn more here: https://lnkd.in/gYVkCsh9 #enhancingvisionforlife #glaucoma #contactlenses #helpprotectsight #drugdelivery #ophthalmology #dryeye

MediPrint is excited to share that Thomas Bender, an industry veteran in the vision care industry, has joined our team as a Strategic Advisor! His extensive expertise will be pivotal in steering the future of our pioneering drug-eluting contact lens technology. Learn more here: https://lnkd.in/g_D-Z9QF #enhancingvisionforlife #glaucoma #contactlenses #helpprotectsight #drugdelivery #ophthalmology #dryeye

MEDI

COM:MEDIPRINTLENS

MediPrint™ Ophthalmics

name

homepage url

country

linkedin url

crunchbase url

sector

industry

stage

raised capital

Description

peer of

competitor of

Metrics